Kirkland Advises BayPine on Acquisition of CenExel

Kirkland & Ellis advised BayPine LP, a private investment firm that drives digital transformation in market-leading businesses, on its definitive agreement to acquire CenExel Clinical Research, Inc., a leading clinical trial site network focused on complex therapeutic areas. Following the closing of the transaction, BayPine will be the majority investor in CenExel alongside previous investor Webster Equity Partners, which will retain a minority stake, as well as CenExcel management. Terms of the transaction were not disclosed. The transaction is subject to customary closing conditions and regulatory approvals and is expected to be completed during the second quarter of 2025.

Read the transaction press release

The Kirkland team included corporate lawyers Ravi Agarwal, Nils Remole, Fiona Blanch and Pete Martelli; debt finance lawyers Adam Shapiro, Paul Rezvani and Taylor Andrews; tax lawyers Mike Beinus and Vivek Ratnam; and healthcare & life sciences regulatory lawyers Dennis Williams and William Richmond.